RULLI, EUGENIO
RULLI, EUGENIO
Università di Padova
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)
2024 Proto, C; Ganzinelli, M; Manglaviti, S; Imbimbo, M; Galli, G; Marabese, M; Zollo, F; Alvisi, M F; Perrino, M; Cordua, N; Borea, F; de Vincenzo, F; Chella, A; Cappelli, S; Pardini, E; Ballatore, Z; Lucarelli, A; Ambrosini, E; Giuliano, M; Pietroluongo, E; Mulargiu, C; Fabbri, A; Prelaj, A; Occhipinti, M; Brambilla, M; Mazzeo, L; Beninato, T; Vigorito, R; Ruggirello, M; Greco, F G; Calareso, G; Miliziano, D; Rulli, E; De Simone, I; Torri, V; de Braud, F G M; Pasello, G; De Placido, P; Berardi, R; Petrini, I; Zucali, P; Garassino, M C; Lo Russo, G
TRAbectedin in adVanced rEtroperitoneal well differentiated/dedifferentiated Liposarcoma and Leiomyosarcoma (TRAVELL): results of a phase II study from the Italian Sarcoma Group
2024 Fabbroni, C; Grignani, G; Vincenzi, B; Fumagalli, E; De Pas, T M; Mazzocca, A; Pantaleo, M A; Brunello, A; Baldi, G G; Boglione, A; Fatigoni, S; Berruti, A; Giordano, M; Marrari, A; Dei Tos, A P; Alberton, A S; Aliberti, S; Carlucci, L; Rulli, E; Casali, P G; Sanfilippo, R